Table 1 Distribution of the clinical variables of the SIDIAP cohort used
| Â | Global | Men | Women |
|---|---|---|---|
N | 49,506 | 19,751 | 29,755 |
BMI (kg/m2) | 30.6 (5.5) | 29.6 (4.7) | 31.4 (5.9) |
Age (years) | 68.2 (12.5) | 66.9 (12) | 69 (12.8) |
Time T2DM (years) | 5.2 (5.3) | 4.7 (4.9) | 5.5 (5.5) |
HbA1c (%) | 6.8 (1.4) | 6.8 (1.4) | 6.8 (1.3) |
Glucose (mg/dL) | 140.5 (42.6) | 142.8 (44.6) | 138.9 (41.2) |
Leukocytes (109/L) | 7.3 (2.0) | 7.4 (2.1) | 7.3 (1.9) |
Monocytes (%) | 7.7 (2.1) | 8.1 (2.1) | 7.4 (2) |
cLDL (mg/dL) | 115.2 (33.0) | 112.1 (33.1) | 117.2 (32.8) |
cHDL (mg/dL) | 50.2 (13.0) | 46.4 (12.0) | 52.7 (13.1) |
Tg (mg/dL) | 133 [97–184] | 130 [94–186] | 134 [100–183] |
DBP (mmHg) | 76.1 (10.0) | 76.4 (10.3) | 75.9 (9.8) |
SBP (mmHg) | 135.6 (15.8) | 135.7 (15.4) | 135.5 (16) |
Serum ferritin (ng/mL) | 81 [33.7–176] | 141 [62–276.9] | 58 [25.8–118] |
Current smoking | 5775 (11.7%) | 4001 (20.3%) | 1774 (6%) |
A10A (Insulin and analogues) | 6568 (13.3%) | 2313 (11.7%) | 4255 (14.3%) |
A10B (Blood glucose lowering drugs, excluding insulins) | 28,820 (58.2%) | 11,433 (57.9%) | 17,387 (58.4%) |
C10 (Lipid modifying agents) | 23,977 (48.4%) | 9462 (47.9%) | 14,515 (48.8%) |
Hypertension medication | 35,996 (72.7%) | 13,786 (69.8%) | 22,210 (74.6%) |